South and Central America Extracellular Matrix Market Growth Drivers and Forecast by 2027

South and Central America Extracellular Matrix Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Application (Vascular Repair and Reconstruction, Dural Repair, Wound Healing, Cardiac Repair, Pericardial Repair, Soft Tissue Repair); Raw Material (Bovine, Porcine, Other Raw Material), and Country

Historic Data: 2017-2018 | Base Year: 2019 | Forecast Period: 2020-2027
  • Status : Published
  • Report Code : TIPRE00016493
  • Category : Life Sciences
  • No. of Pages : 144
  • Available Report Formats : pdf-format excel-format
  • Last update date : February 04, 2021
South and Central America Extracellular Matrix Market Growth Drivers and Forecast by 2027
Report Date: February 04, 2021   |   Report Code: TIPRE00016493 Email: sales@theinsightpartners.com

2019 Market Size

US$ 989.99 Th

Base year value

2027 Forecast

US$ 11,708.44 Th

Projected by 2027

CAGR 2020-2027

7.1 %

Growth rate

Addressable Market

US$ 10,917.51 Th

(2020-2027)

The South and Central America extracellular matrix market was valued at US$ 989.99 thousand in 2019 and is projected to reach US$ 11,708.44 thousand by 2027; it is expected to grow at a CAGR of 7.1%  from 2020 to 2027.

The growth of the market is attributed to the increasing incidences of trauma and cardiovascular diseases, and increasing vascular reconstruction procedures. However, the challenges associated with the usage of decellularized extracellular matrix such as , insufficient preservation of vasculature and extracellular matrix composition hinders the growth of the market.

The significantly rising incidences of the orthopaedic trauma conditions and cardiovascular diseases among others are the leading factors for the South and Central America Extracellular Matrix market growth. As a part of the treatment extracellular matrix serve several advantages for treating different chronic injuries caused due to surgery, accidents, chronic diseases and others. Chronic diseases such as cancer, heart diseases, musculoskeletal diseases, and others are the leading causes of death and disability. The awareness about the technologically advanced treatment and minimally invasive procedures demands treatments that are effective in less time. Thus, one of the advantages of the extracellular matrix serve the demand of the patients.

Additionally, the COVID-19 outbreak is negatively impacting the overburdened and underfunded healthcare systems of South and Central America. Hospitals are already overstressed by the treatment of vector‐borne diseases and community‐acquired infections and high rates of non‐communicable diseases (NCDs). Since the onset of the COVID-19, the prevention and treatment of NCDs such as diabetes and its associated complications have been critically affected in the region, as per the Pan American Health Organization (PAHO).

South and Central America Extracellular Matrix Market Revenue and Forecast to 2027 (US$ Thousand)

South and Central America Extracellular Matrix Market Revenue and Forecast to 2027 (US$ Thousand)
  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

South and Central America Extracellular Matrix Market Segmentation

By Application

  • Vascular Repair and Reconstruction
  • Dural Repair
  • Wound Healing
  • Cardiac Repair
  • Pericardial Repair
  • Soft Tissue Repair


By Raw Material

  • Bovine
  • Porcine
  • Other Raw Material

Company Profiles          

  • Organogenesis Inc.
  • Integra Life Sciences Corporation
  • Mölnlycke Health Care AB
  • Anika Therapeutics, Inc.
  • ACell Inc.
  • MIROMATRIX MEDICAL Inc
  • Acera Surgical Inc., CorMatrix, Inc.
  • Hollister Incorporated
  • MLM Biologics Inc.
  • Harbor MedTech, Inc.

South and Central America Extracellular Matrix Report Scope

Report Attribute Details
Market size in 2019 US$ 989.99 thousand
Market Size by 2027 US$ 11,708.44 thousand
CAGR (2020 - 2027) 7.1%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Application
  • Vascular Repair and Reconstruction
  • Dural Repair
  • Wound Healing
  • Cardiac Repair
  • Pericardial Repair
  • Soft Tissue Repair
By Raw Material
  • Bovine
  • Porcine
  • Other Raw Material
Regions and Countries Covered South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Market leaders and key company profiles
  • Organogenesis Inc.
  • Integra Life Sciences Corporation
  • M
Trupti Wadekar
Assistant Manager,
Market Research & Consulting

Trupti is a senior consultant with over 10 years of experience in the Healthcare sector, specializing in pharmaceuticals, biotechnology, and life-sciences markets. She holds a Bachelor’s degree in Biotechnology and an MBA with dual specialization in Marketing and Pharmaceuticals & Biotechnology, combining a strong scientific foundation with a strategic and commercial perspective. Her professional experience encompasses market research, competitive intelligence, strategic advisory, and business development, supporting clients across diverse and evolving healthcare markets.

She has worked extensively on market sizing and assessment, growth strategy, market expansion, and strategic decision-making initiatives, helping clients identify opportunities and address complex business challenges. Trupti brings strong expertise in client engagement, stakeholder management, team leadership, and translating research findings into actionable business insights. Her ability to connect scientific understanding with market dynamics and commercial strategy enables her to deliver practical, high-impact solutions aligned with client objectives.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA